Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.40745
-0.0446 (-9.86%)
At close: Nov 20, 2026, 4:00 PM EST
0.4170
+0.0096 (2.34%)
After-hours: Nov 20, 2026, 7:30 PM EST
Daré Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
| 8 | 17 | 32 | 26 | 28 | 28 | 21 | 26 | 27 | 28 | 34 | 49 | 30 | 45 | 79 | 90 | 70 | 85 | 104 | 125 | 153 | |
Market Cap Growth (YoY) | -68.45% | -39.36% | 49.42% | 3.60% | 1.59% | -0.05% | -37.74% | -48.12% | -10.87% | -39.00% | -56.73% | -44.99% | -56.74% | -46.49% | -24.63% | -28.34% | -54.05% | -27.98% | 11.71% | 56.43% | 178.42% |
Enterprise Value | 3 | 11 | 20 | 10 | 13 | 26 | 14 | 11 | 17 | 17 | 32 | 40 | 17 | 32 | 59 | 55 | 31 | 54 | 66 | 74 | 108 |
Last Close Price | 0.41 | 0.85 | 2.11 | 1.82 | 1.93 | 2.10 | 2.39 | 2.89 | 3.12 | 3.24 | 4.03 | 5.88 | 3.71 | 5.54 | 10.92 | 12.48 | 9.96 | 12.00 | 14.76 | 17.88 | 24.00 |
Price Ratios
Fiscal Quarter | Current | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | - | - | - | - | - | -4.72 | - | - | - | - | - | - | - | -3.45 | - | - |
PS Ratio | 5.68 | 11.89 | 23.14 | 22.90 | 26.77 | -484.46 | -1194.98 | 987.21 | 2774.45 | 14.72 | 11.97 | 17.50 | 10.85 | 45.39 | - | - | - | - | 10.42 | - | - |
PB Ratio | 3.42 | 7.17 | -56.43 | 36.08 | 9.70 | 9.68 | -1.66 | -2.67 | -4.51 | -18.65 | 12.72 | -4.48 | -6.03 | -19.83 | -28.88 | 18.03 | 6.34 | 3.22 | 3.15 | 4.05 | 3.95 |
P/TBV Ratio | 3.42 | 7.17 | - | 36.11 | 9.70 | 9.68 | - | - | - | - | 12.72 | - | - | - | - | 18.03 | 6.34 | 3.22 | 3.15 | 4.05 | 3.95 |
P/FCF Ratio | - | - | - | - | -2.68 | - | - | - | 5.54 | - | -3.09 | - | - | - | - | - | - | -3.83 | - | - | - |
P/OCF Ratio | - | - | - | - | -2.79 | - | - | - | 4.96 | - | -3.38 | - | - | - | - | - | - | -3.84 | - | - | - |
EV Ratios
Fiscal Quarter | Current | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.33 | 7.75 | 14.84 | 8.50 | 12.30 | -449.41 | - | 431.61 | - | 9.09 | 11.27 | 14.28 | 5.97 | 32.36 | - | - | - | - | 6.61 | - | - |
EV/EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.19 | - | - |
EV/EBIT Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.19 | - | - |
EV/FCF Ratio | - | - | - | - | -1.23 | - | - | - | 3.53 | - | -2.91 | - | - | - | - | - | - | -2.43 | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.90 | 2.90 | -12.08 | 9.78 | 2.83 | 2.86 | -0.24 | -0.37 | -1.01 | -0.95 | 2.18 | -0.15 | -0.28 | -0.08 | -0.11 | 0.08 | 0.04 | 0.02 | 0.04 | 0.04 | 0.01 |
Debt / EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.53 | - | - |
Debt / FCF Ratio | - | - | - | - | -0.78 | - | - | - | 1.24 | - | -0.53 | - | - | - | - | - | - | -0.03 | - | - | - |
Net Debt / Equity Ratio | -2.02 | -2.02 | 10.45 | -15.44 | -5.86 | -5.22 | 0.16 | 0.71 | 1.60 | 6.62 | -3.96 | 0.18 | 1.80 | 5.99 | 4.79 | -3.91 | -3.08 | -1.51 | -0.94 | -1.23 | -1.33 |
Net Debt / EBITDA Ratio | 0.56 | 0.57 | 0.65 | 1.14 | 1.40 | 0.91 | 0.11 | 0.31 | 0.41 | 0.43 | 0.40 | 0.07 | 0.30 | 0.33 | 0.32 | 0.62 | 1.09 | 1.61 | 1.02 | 0.96 | 1.32 |
Net Debt / FCF Ratio | 0.26 | 0.26 | 0.50 | 1.12 | 1.62 | 2.20 | 0.17 | -1.11 | -1.97 | 1.14 | 0.96 | 0.07 | 0.23 | 0.37 | 0.65 | 0.89 | 1.88 | 1.80 | 1.05 | 1.16 | 1.79 |
Asset Turnover | 0.05 | 0.05 | 0.08 | 0.05 | 0.04 | - | - | 0.00 | 0 | 0.09 | 0.12 | 0.13 | 0.09 | 0.03 | - | 0.25 | 0.20 | 0.20 | 0.30 | - | - |
Quick Ratio | 0.93 | 0.93 | 0.75 | 0.89 | 1.07 | 1.11 | 0.27 | 0.49 | 0.74 | 0.89 | 1.19 | 0.28 | 0.56 | 0.57 | 0.56 | 0.91 | 1.15 | 1.87 | 2.67 | 2.50 | 3.29 |
Current Ratio | 1.23 | 1.23 | 0.99 | 1.03 | 1.14 | 1.18 | 0.34 | 0.56 | 0.85 | 1.14 | 1.43 | 0.56 | 0.86 | 0.85 | 0.90 | 1.21 | 1.36 | 2.17 | 3.03 | 2.92 | 3.45 |
Return on Equity (ROE) | -407.07% | -407.07% | - | - | - | -2543.13% | - | - | - | - | - | - | -994.69% | -341.28% | -262.37% | -170.66% | -124.12% | -84.31% | -148.09% | -233.01% | -205.82% |
Return on Assets (ROA) | -40.05% | -40.05% | -62.16% | -51.76% | -49.10% | -71.56% | -101.70% | -10.60% | -18.69% | -16.72% | -30.76% | -133.12% | -92.65% | -108.83% | -106.61% | -76.91% | -62.12% | -49.50% | -91.20% | -133.22% | -122.15% |
Return on Capital Employed (ROCE) | -125.60% | -125.60% | -204.00% | -178.40% | -154.20% | -183.30% | 296.10% | 856.70% | -4805.00% | -469.80% | -296.70% | 602.30% | -3834.00% | 3258.90% | 2732.70% | -520.30% | -257.20% | -89.70% | -86.70% | -121.30% | -98.30% |
Yields
Fiscal Quarter | Current | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -170.85% | -63.05% | -34.76% | -45.37% | -48.59% | -63.10% | -87.95% | -6.55% | -14.93% | -13.02% | -21.20% | -58.56% | -99.03% | -90.43% | -50.64% | -34.13% | -43.96% | -28.94% | -28.98% | -31.80% | -25.26% |
FCF Yield | -226.96% | -108.37% | -37.19% | -38.36% | -37.24% | -24.45% | -55.74% | 23.82% | 18.05% | -31.16% | -32.32% | -61.23% | -129.65% | -80.63% | -25.54% | -24.46% | -25.78% | -26.14% | -28.22% | -26.18% | -18.79% |
Buyback Yield / Dilution | -59.34% | -36.59% | -67.84% | -65.80% | -78.14% | -49.45% | -4.66% | -4.57% | -9.92% | -12.48% | -17.72% | -17.54% | -7.26% | -7.34% | -1.21% | -1.87% | -56.89% | -19.85% | -69.26% | -88.63% | -36.12% |